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Abstract
HIV-related fatigue remains the most troubling complaint of seropositive people. Researchers
often use tools to measure fatigue that were developed for other patient populations; thus, the
measurement of fatigue specific to HIV is needed. This article describes results from the HIV-
Related Fatigue Scale (HRFS) including: (a) the variability in intensity and chronicity of HIV-
related fatigue, (b) the circumstances surrounding changes in fatigue, (c) the impact of fatigue on
activities of daily living (ADLs), and (d) the consequences of HIV-related fatigue. We collected
data every 3 months over a 3-year period from 128 people. HIV-related fatigue was chronic and
did not appear to remit spontaneously; those who were the most fatigued at the beginning of the
study remained the most fatigued over 3 years. Fatigue interfered more with instrumental activities





Thirty years into the AIDS epidemic, fatigue remains the most frequent and debilitating
complaint of HIV-infected people (e.g., Dacosta Dibonaventura, Gupta, Cho, & Mrus, 2012;
Holzemer, 2002; Jong et al., 2010; Justice, Rabeneck, Hays, Wu, & Bozzette, 1999;
Paddison, Fricchione, Ghandi, & Freudenreich, 2009; Sullivan & Dworkin, 2003). While
there have been several studies examining factors related to fatigue in HIV-infected
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individuals, advancing research in this area has been hampered in part by a lack of
consistent measurement of fatigue as the primary variable of interest. We described in 2002
some of the measurement problems: simple dichotomous measurement of the presence or
absence of fatigue; measurement of the intensity of fatigue only; or measurement of the
effects of fatigue on some other variable, such as employment (Barroso & Lynn, 2002).
None of the existing fatigue measures were developed for HIV-infected individuals, and
most were developed specifically for other diseases, such as cancer, rheumatoid arthritis, or
multiple sclerosis. The features of fatigue that are relevant in these illnesses are very
different than those relevant in HIV infection. Finally, most were very brief—four questions
or less (Barroso & Lynn, 2002).
Need for a New Instrument to Measure Fatigue in HIV Infection
Extensive review of measurement of fatigue in people who are HIV-infected and completion
of a qualitative study that obtained a detailed description of HIV-related fatigue (Barroso,
2001) made it clear that there was a need for an instrument that would measure the relevant
features of fatigue as it is experienced by HIV-infected people. Thus, the first author
developed the HIV-Related Fatigue Scale (HRFS). Details about its development and initial
psychometric testing are reported in Barroso & Lynn (2002). We knew that we had to clarify
the important conceptual domains relative to HIV-related fatigue prior to being able to
measure it; we decided that we needed to measure the intensity of fatigue, its chronicity, the
consequences of fatigue, and the circumstances surrounding its worsening or improvement.
Measurement of intensity would help assess the degree to which a person was experiencing
fatigue, and would also help us know if an intervention was effective. Measuring the
chronicity of fatigue helps us to determine a trajectory that would be useful in knowing
when we could intervene most effectively. Measuring the consequences of fatigue helps us
to understand which aspects of a person's life are most adversely impacted by fatigue, which
helps us know how to direct interventions. Finally, measuring the circumstances of fatigue
helps us know the patterns of fatigue, which can be most useful in helping patients plan
around such a symptom, and to help us see if there are clusters of patients who have similar
aggravating and alleviating factors; this may help in the development of self-care measures
(Barroso & Lynn, 2002).
Development of the HIV-Related Fatigue Scale
The 56-item HRFS (Barroso & Lynn, 2002) was developed from five existing scales (with
these authors' permission). Several additional items were developed based on our qualitative
work. The following three broad areas were measured: (a) intensity of fatigue (8 items), (b)
fatigue-related impairment of functioning (22 items), and (c) responsiveness of fatigue to
circumstances (15 items). The remaining items are descriptive, and will be described in
detail in this article. The fatigue-related impairment of functioning items can be further
divided into three subcategories: impairment of activities of daily living (12 items),
impairment of socialization (6 items), and impairment of mental functioning (4 items, Pence,
Barroso, Leserman, Harmon, & Salahuddin, 2008). All scales are coded from 1 to 10, with
higher numbers indicating more fatigue, more impairment, or more responsiveness.
Regarding reliability of the HRFS, all scales and subscales demonstrated acceptable internal
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consistency. Values for Cronbach's α were high for the main scales of fatigue intensity
(0.93), fatigue-related impairment of functioning (0.97), and responsiveness of fatigue to
circumstances (0.91), and for the subscales of the fatigue-related impairment of functioning
scale: impairment of ADL (0.95), impairment of socialization (0.93), and impairment of
mental functioning (0.92). The HRFS scales also demonstrated satisfactory convergent
validity when compared to other fatigue instruments measuring similar constructs. The
HRFS was moderately correlated with quality of nighttime sleep but showed only weak
correlations with daytime sleepiness, which was expected, as sleepiness is conceptually
distinct from fatigue. The scales were also moderately correlated with general mental and
physical health as measured by the SF-36 Health Survey (for a detailed examination of the
psychometric properties of the HRFS, see Pence et al., 2008).
While this article is reporting primarily the detailed results of the HRFS data, we have
reported other findings from this study. Harmon et al. (2008) reported the demographic and
illness-related characteristics of the sample; Pence et al. (2008) reported the psychometric
properties of the HRFS; Barroso et al. (2008) reported the physiological correlates of
fatigue; Leserman et al. (2008) reported the psychosocial correlates of fatigue; Salahuddin et
al. (2009) examined HIV-related fatigue, daytime sleepiness, and impaired nighttime sleep;
Pence et al. (2009) reported data about chro-nicity and remission of fatigue in this sample;
and Barroso et al. (2010) reported the effects of examining both physiological and
psychosocial data together in determining factors associated with increases in fatigue.
Method
Participants were recruited by posting flyers advertising the study at clinics serving persons
with HIV infection in a southern U.S. state, as well as the primary AIDS service
organization in this community. Interested individuals were invited to participate if they met
the following inclusion criteria: (a) HIV-positive, (b) ≥ 21 years old, (c) able to read and
speak English competently, and (d) mentally competent to provide reliable data. Both
fatigued and nonfatigued individuals were eligible to enroll. Individuals were excluded if
they had a comorbid condition marked by fatigue such as renal disease, cancer, or multiple
sclerosis. Pregnant women and women less than 12 months postpartum were also excluded,
as fatigue is a prominent feature of both pregnancy and the postpartum period. The PI
screened all potential participants via telephone. All study procedures were approved by a
university Institutional Review Board and all study participants provided written informed
consent. The sample is described in Table 1.
The sample (n = 128) was predominantly comprised of persons who had lived with HIV
infection for many years, with a median time since diagnosis of 10 years. Most participants
(82%) were on antiretroviral therapy at baseline. Many (65%) reported at least one other
comorbid chronic illness. The majority of the 128 participants were African American
(66%), and 66% of the subjects were male. Most participants were in their late 30s or 40s
(median age = 44 years). A majority of the participants were unemployed at baseline (67%,
Harmon et al., 2008).
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These participants had seven study visits over a 3-year period; there was a baseline visit and
then visits every 6 months. At each study visit, they completed a large number of
questionnaires for measurement of psychoso-cial variables, and had blood drawn for
measurement of physiological variables; they completed the HRFS at each study visit. Then,
at 3-month intervals in between study visits, the HRFS was mailed to them to complete and
return to us in order for us to more closely track changes in fatigue over the 3-year study
period.
Results
We report here the results of a detailed, item by item analysis of the items of the HRFS,
completed by participants every 3 months for 3 years. Descriptive information is presented
on the proportion of responses in the most severe range on each question (≥ 7 for questions
scored on a 1-10 scale). To draw on the full richness of the data, we report the proportion of
responses in the most severe range out of all surveys collected from all participants (1,379
surveys from 128 participants over 13 rounds of data collection). Thus, the figures illustrate
the responses that reveal the greatest adverse impact of fatigue, and each item represents
1,379 responses to that item over a 3-year period.
The first set of questions refers to fatigue intensity. Overall, 39.5% of surveys indicated that
fatigue had caused the respondent distress, 53.8% indicated that the respondent was easily
fatigued, and 55.7% indicated that that fatigue caused frequent problems for the respondent.
Of all surveys, 61.6% indicated that the respondent had often been fatigued in the week prior
to data collection.
We were particularly intrigued by the data about chronicity of fatigue. We hypothesized
going into the study that participants would exhibit quite a bit of variability in their fatigue,
being more fatigued at some visits than others. This was based on findings—our own and
others—that fatigue was unpredictable and that it was difficult to determine patterns.
However, there was remarkably little convergence between the most and least fatigued over
the 36 months of the study (see Figures 1a and b). The participants with the highest quintile
of fatigue at study entry remained the most fatigued over time, with a slight improvement in
the first 6 months but virtually no change thereafter. This is important to know with regard
to targeting interventions. The same pattern was discovered for fatigue-related impairment
of functioning: the participants in the highest quintile of impairment at baseline remained the
most impaired, with little convergence over time between the most and least impaired.
For all of the data described below, the number in parentheses refers to the percentage of
surveys with scores in the most severe range. With regard to impairment of functioning,
fatigue interfered with the participants' abilities to complete the following activities of daily
living: dressing (14.6%), bathing/washing (15.5%), cooking (26.3%), shopping/errands
(28.8%), household chores (31.0%), planning activities (32.0%), walking (32.1%), working
(34.2%), exercise other than walking (38.7%), sustained physical functioning (61.2%),
carrying out duties/responsibilities (59.9%), and physical functioning (61.2%, see Figure 2).
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With regard to impairment of socialization, fatigue interfered with visiting/ socializing
(27.0%), interactions with others outside the home (28.6%), controlling their temper
(30.7%), leisure/recreation (31.5%), sexual activity (32.4%), and work, family, and social
life (60.6%). Impaired mental functioning is another outcome of HIV-related fatigue; those
who are most fatigued reported problems with learning new things (28.8%), thinking clearly
(30.1%), thinking quickly (33.6%), and concentration (67.5%, see Figure 3).
We asked about things that participants thought brought on/increased their fatigue: HIV
medications (40.0% of the surveys with scores in the most severe range); exercise (42.0%),
with 45.6% reporting prolonged fatigue after exercise; performance of activities of daily
living (45.4%); long periods of inactivity (46.0%); work (49.3%); heat (60.7%); depression
(65.6%); and stress (67.5%). Participants reported that fatigue was alleviated by the
following: cool temperatures (48.0% of the surveys with scores in the most severe range),
positive experiences (53.3%), rest (53.9%), and sleeping (53.9%, see Figure 4).
Other items asked for descriptions surrounding the experience of fatigue. Nearly half of the
surveys with scores in the most severe range indicated that fatigue was worse in the
afternoon (49.2%), while 30.5% indicated that it was worse in the morning. About a third of
the surveys with scores in the most severe range (37.2%) indicated that fatigue started before
other HIV-related symptoms. Fatigue caused them to eat less (40.8% of the surveys). Nearly
half (49.2%) indicated that fatigue was their most disabling symptom; 66.3% indicated that
fatigue was among their 3 most disabling symptoms. Fatigue since becoming HIV-infected
was different than pre-HIV fatigue (62.5% of the surveys with scores in the most severe
range). Many of those who were most fatigued said that their fatigue had changed during
past week (54.8% of the surveys), and 54.8% indicated that their fatigue was unpredictable.
Over half (57.4% of the surveys) indicated that fatigue made other symptoms worse. Fatigue
caused them to lose their patience (59.3% of the surveys). Nearly two thirds (64.6% of the
surveys) indicated that they feel drowsy when fatigued, and 72.8% of the surveys reported
that fatigue lessened their motivation (see Figure 5).
Discussion
This study is significant because it is the first to report prospective, longitudinal data on
fatigue in HIV-infected study participants with a tool developed specifically to measure
fatigue in this population. The data reported here represent items endorsed by those most
adversely impacted by HIV-related fatigue (scores ≥ 7 on each 1-10 scale), and each item
represents nearly 1,400 responses to that item. Thus, this report represents the largest, most
comprehensive analysis of HIV-related fatigue to date. As such, it extends our
understanding of all of the domains that are associated with this symptom, and goes far
beyond the simple measurement of presence and intensity that is commonly reported.
We chose to select items for inclusion in the HRFS and to group the items into scales based
on the conceptual framework and dimensions identified through formative qualitative
research rather than employing a data-driven procedure such as exploratory factor analysis.
While there is some conceptual overlap, as evidenced by the strong correlations of the three
HRFS sub-scales, this overlap is critical to helping us gain a deep understanding of
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phenomenon (Pence et al., 2008). It is important to know about both fatigue intensity and
fatigue-related impairment of functioning, as a person can have intense fatigue but have no
impairment of functioning, or they can have impairment of functioning from something
other than fatigue. In either case, these are not the people most in need of interventions.
Those that report intense fatigue AND impairment of functioning because of the fatigue
should be the group to whom interventions would be targeted.
There are limitations to the study. We admitted participants based on self-referral, and those
who responded to the study flyers may have been more severely fatigued. However, the
participants in the study closely matched the demographic profile of people infected with
HIV in our geographical area. Finally, because we had so little change in the profile of those
who were most fatigued, we do not know if the tool will be sensitive enough to measure
change in an intervention study. However, we also gained important knowledge from this
examination of the HRFS. Most surprising was the finding that those who entered the study
with the most fatigue remained the most fatigued over three years; we expected to observe
more variability in fatigue over a 3-year period. HIV-related fatigue appears to be chronic
and generally does not remit, making the search for interventions more pressing. While there
was little impairment with basic activities of daily living, more advanced (or instrumental)
activities of daily living were more of a problem. This may help direct resources for those
who are fatigued; instrumental ADLs are those that allow people to remain independent in
the community and able to avoid more intense, expensive services.
HIV-related fatigue clearly impacts socialization and mental functioning; many of the
activities listed in these two areas are those that keep people in the workforce, which again
has economic implications. The ability to socialize involves something more important,
however, and that is the person's ability to be with friends and family. When people have to
withdraw from interacting with others because they are too tired to do so, the risk of
depression increases, and there is a strong relationship between fatigue and depression in
HIV infection (e.g., Barroso, 2001; Barroso et al., 2003; Barroso et al., 2010; Barroso &
Lynn, 2002; Breitbart et al.1998; Henderson et al., 2005; Millikin, Rourke, Halman, &
Power, 2003; Phillips et al., 2004; Schifitto et al., 2011; Voss, 2005). Fatigue can cause
depression, and depression has fatigue as one of its cardinal symptoms. Thus, social
withdrawal by a fatigued HIV-infected individual may signal the beginning of a cascade of
negative events.
With regard to recommendations for the future, knowing the aggravating and alleviating
factors helps us provide anticipatory guidance to patients with HIV-related fatigue; we can
let them know what things may make their fatigue worse and what may make it better. The
relationship among stress, depression, and fatigue was in fact borne out by more
sophisticated analyses of our data with separate measures for stress and depression (Barroso
et al., 2010; Leserman et al., 2008). Helping people learn better coping strategies when they
face stressful events may help them avoid depression and fatigue. It is conceivable as well
that fatigue, depression, and stress form a symptom cluster, and therefore we would need to
deal with all three symptoms to impact any of them. Finally, the notion of a symptom cluster
is also supported by the fact that this is a different type of fatigue from that experienced
prior to becoming HIV-infected, that it is perceived as disabling, and that it amplifies other
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symptoms. Thus, further investigation of fatigue, depression, and anxiety as a symptom
cluster appears to be merited. The development of interventions that take all three symptoms
into account is likely needed. As we enter the fourth decade of the epidemic, important new
scientific developments such as treatment as prevention, have led to a global discourse about
the beginning of the end of AIDS, yet, it is important to remember that the people who are
already infected continue to suffer from a fatigue that is for many a true impediment to a
better quality of life. Thus, the search for interventions must continue.
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A: Fatigue intensity by quartile over 36 months; B: Fatigue-related impairment of
functioning by quartile over 36 months.
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The impact of fatigue on basic and instrumental activities of daily living.
Barroso et al. Page 10























The impact of fatigue on socialization and mental functioning.
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HIV-related fatigue: Precipitating and alleviating factors.
Barroso et al. Page 12























Description of fatigue as a symptom.
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Table 1
Description of Sample.
Characteristic N (%) or Median (IQR)*
Demographic
Age, years (range: 26-66) 44 (38-48)
Male gender 84 (65.6%)
Race:
 African American 84 (65.6%)
 Caucasian 39 (30.5%)
 Other 5 (3.9%)
Years of schooling (range: 4-20) 12 (12-14)
Employed part/full time 42 (32.8%)
Monthly income, $ (range: 0-6,000) 685 (501-1,300)
Clinical
Years since HIV diagnosis (range: 0-25) 10 (6-15)
On any antiretroviral therapy 105 (82.0%)
CD4 count, cells/mm3 (range: 29-1755) 457 (268-670)
HIV RNA viral load < 400 copies/mL 87 (68.0%)
Fatigue course
Fatigued at baseline 111 (88.1%)
Experienced remission of fatigue during follow-up** 11 (10.7%)
Note:
*
IQR = interquartile range (25th-75th percentile).
**
Of 103 participants fatigued at baseline and with at least one follow-up visit.
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